Parameters | aOR (95% CI) with hepatic adverse events | ||
---|---|---|---|
Elevated ALT LR-p value: 0.025 | Elevated AST LR-p: <0.001 | Elevated total bilirubin LR-p: 0.001 | |
Episode groups | |||
First treatment | 1 | 1 | 1 |
Retreatment | 0.24 (0.08; 0.70) * | 0.16 (0.06; 0.41) *** | 2.48 (1.31; 4.69) ** |
Age | 0.96 (0.87; 1.05) | 0.83 (0.73;0.93) ** | 1.05 (1.02; 1.09) ** |
Sex | |||
Female | 1 | 1 | 1 |
Male | 1.96 (0.67; 5.77) | 0.80 (0.34; 1.84) | 1.04 (0.61; 1.75) |